LIPOCINE INC. Deferred Revenue
LIPOCINE INC. (LPCN) had Deferred Revenue of $320.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-08-04
- 2026-06-30: Deferred Revenue $320.00K.
- 2026-03-31: Deferred Revenue $320.00K.
- 2025-12-31: Deferred Revenue $320.00K.
- 2025-09-30: Deferred Revenue $320.00K.
| Period end | Deferred Revenue |
|---|---|
| 2026-06-30 | $320.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $320.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $320.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $320.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $320.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $320.00K 10-Q · filed 2026-05-07 |
| 2024-12-31 | $320.00K 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |